• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

New Delhi, April 1

RFCL Ltd, an ICICI Venture company, has announced its first global acquisition in the space of veterinary health care through a share purchase agreement with Marsung & Co Ltd A/S for its Germany-based subsidiary Bremer Pharma GmbH. Bremer Pharma has 803 global registrations across Europe, West Asia, Asia and Africa. The agreement is for transfer of all key people, assets, brands, all contracts including exports. With this, RFCL will get a marketing foothold in the city of Bremerhaven, near Hamburg. The acquisition follows the buyout of Alved in January. RFCL’s animal healthcare business under Vetnes will achieve a turnover of Rs 90 crore for 2008. Combined with sales revenue of Bremer Pharma and Alved, RFCL’s veterinary product portfolio will be in excess of Rs 160 crore.

— Our Bureau

More Stories on : Mergers & Acquisitions | Overseas Investments

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Reliance makes another find in Krishna basin

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line